Methyl jasmonate and its potential in cancer therapy

20Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Methyl jasmonate (MeJa) is a naturally occurring hydrophobic oxylipin phytohormone. Early findings obtained from cancer cell lines suggest that MeJa is endowed with anticancer capabilities. It has been recently proposed that MeJa represents a novel agent that exhibits direct and selective actions against tumor cells without affecting normal human cells. In a previous study, I reported that MeJa itself is enough to result in the dysfunction of mitochondria and chloroplasts, as well as to activate cell death program (apoptosis), in the normal protoplasts of Arabidopsis thaliana. Indeed, this also holds true for other living plant systems in which senescence, hypersensitive response and oxidative stress have been found under MeJa action. Therefore, in this addendum to my previous article, I would like to stress that much more attention should be paid to the potential effect(s) of MeJa, or its derivatives, on healthy cells and tissues before it is used for clinical anticancer drugs, whether being used alone or in combination with other agents.

References Powered by Scopus

The jasmonate signal pathway

932Citations
N/AReaders
Get full text

The outcomes of concentration-specific interactions between salicylate and jasmonate signaling include synergy, antagonism, and oxidative stress leading to cell death

692Citations
N/AReaders
Get full text

Evidence supporting a role of jasmonic acid in Arabidopsis leaf senescence

599Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chemical regulators of plant hormones and their applications in basic research and agriculture

109Citations
N/AReaders
Get full text

Anti-inflammatory and antioxidant actions of methyl jasmonate are associated with metabolic modifications in the liver of arthritic rats

35Citations
N/AReaders
Get full text

Arctium lappa L. root extract induces cell death via mitochondrial-mediated caspase-dependent apoptosis in Jurkat human leukemic T cells

28Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, M., Zhang, M. W., Zhang, L., & Zhang, L. (2015). Methyl jasmonate and its potential in cancer therapy. Plant Signaling and Behavior, 10(9). https://doi.org/10.1080/15592324.2015.1062199

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

83%

Researcher 3

17%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 10

50%

Chemistry 4

20%

Pharmacology, Toxicology and Pharmaceut... 3

15%

Biochemistry, Genetics and Molecular Bi... 3

15%

Article Metrics

Tooltip
Mentions
References: 5
Social Media
Shares, Likes & Comments: 27

Save time finding and organizing research with Mendeley

Sign up for free
0